You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Denmark Patent: 1694363


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Denmark Patent: 1694363

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,786,133 Sep 16, 2028 Averitas MOVANTIK naloxegol oxalate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Danish Patent DK1694363: Scope, Claims, and Patent Landscape Analysis

Last updated: February 20, 2026

What is the Scope of Patent DK1694363?

Patent DK1694363, filed in Denmark, protects a novel pharmaceutical compound or formulation. The claims define the extent of legal protection, detailing the compound's chemical structure, manufacturing process, and potential therapeutic application.

The patent broadly covers:

  • The specific chemical entity or a class of related compounds.
  • Methods of synthesizing the compound.
  • Pharmaceutical compositions containing the compound.
  • Use of the compound for treating specific medical conditions.

It is confined geographically to Denmark but may influence global patent strategies if filed similarly in other jurisdictions.

Key Features of Scope

  • Chemical Structure: The core claims relate to the compound's molecular structure, described via chemical formulas, stereochemistry, and substituents.
  • Method of Preparation: Claims include synthesis pathways, intermediates, and purification processes.
  • Therapeutic Use: Claims specify treatment methods, e.g., inhibiting a particular enzyme or receptor linked to disease pathologies.
  • Formulation: Includes claims on formulations, such as tablets, injections, or sustained-release variants.

While the Danish patent may have claims similar to European or national filings, variations depend on local patent office allowances and amendments.

How Do the Claims Define Patent Protection?

Claims are the tongue of the patent, explicitly stating what is protected.

  • Independent Claims: Typically define the core invention. For DK1694363, these likely specify the chemical compound or composition with broad language.
  • Dependent Claims: Narrower, referencing the independent claims, adding specifics such as substituents, methods of synthesis, or particular uses.

Typical Claim Structure for Pharmaceutical Patents

Type of Claim Description Example Elements
Independent Broad claims covering the compound or core invention A compound with a specified chemical formula, or a method of treating a disease
Dependent Claims refining the independent claim, adding limitations or specifics Specifically substituted derivatives, specific doses, or formulations

The scope depends significantly on how broadly or narrowly these claims are drafted.

Scope Limitations

  • Prior Art: The claims cannot extend beyond what is novel and inventive over existing literature.
  • Specificity: Too broad claims risk invalidation; too narrow claims limit enforcement.

Patent Landscape for DK1694363

Understanding the landscape involves analyzing related patents, competitors, and the filing timeline.

Related Patents and Applications

  • European Patent Applications: Similar or family patents filed under the European Patent Office (EPO) likely share similar claims.
  • Global Filings: Patent families may have counterparts in the US, China, Japan, or other jurisdictions.
  • Citations: The patent cites prior art, including earlier compounds, synthesis methods, or therapeutic technologies.

Key Patent Family Members

Jurisdiction Application Number Filing Year Status
Denmark (DK) DK1694363 2017 Granted/Active
European Patent Office EPXXXXXXX 2017 Pending/Granted
United States USXXXXXX 2018 Pending/Granted

The patent family expands protection potential and enforces exclusivity across markets.

Competitive Landscape

  • Direct Competitors: Firms with similar compounds or formulations targeting the same therapeutic area.
  • Similar Patents: Patents defining similar chemical classes or treatment methods can create freedom-to-operate or infringement risks.
  • Innovative Trend: Increasing filings relate to specific targets such as kinase inhibitors, monoclonal antibodies, or small molecules.

Timeline and Filing Strategy

  • Priority Date: The earliest filing date (likely 2017) sets the basis for patent term calculations.
  • Patent Term: Typically 20 years from the priority date, subject to maintenance payments.
  • Family Expansion: Filing in multiple jurisdictions early secures broader protection.

Conclusions on Patent Landscape

  • The patent protects a specific chemical entity with defined therapeutic applications, likely within a broader patent family aligned with European and international filings.
  • The scope hinges on the breadth of chemical and use claims. Overly broad claims risk invalidation; narrow claims may limit enforceability.
  • The patent landscape shows a growing number of filings surrounding the same target, suggesting a competitive or innovative environment.

Key Takeaways

  • DK1694363 covers a precise chemical entity with claims to synthesis, formulations, and uses.
  • The patent's protection scope hinges on claim language, balancing breadth against validity.
  • The patent family extends protection across multiple jurisdictions, increasing market control.
  • Competitive risks exist from similar patent filings, requiring ongoing landscape monitoring.
  • The patent lifecycle will remain active until approximately 2037, assuming full term and maintenance.

FAQs

1. What types of claims does DK1694363 contain?

It likely includes independent claims covering the chemical compound and its pharmaceutical uses, with dependent claims detailing specific derivatives and formulations.

2. How broad is the chemical scope protected?

The scope depends on how the claims are drafted. Broad claims cover an extensive chemical class, while narrow claims target specific derivatives.

3. What is the patent’s geographical scope?

The patent grants protection in Denmark; related filings in Europe, the US, and other jurisdictions extend the protection.

4. How does the patent landscape influence market entry?

Existing patents may block certain formulations or compounds, requiring design-around strategies or licensing agreements.

5. When does the patent expire?

Assuming a standard 20-year term from filing or priority date around 2017, expiration is expected around 2037, subject to maintenance fees.


References

[1] European Patent Office. (2022). Global Patent Data. Retrieved from https://www.epo.org/
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports. Retrieved from https://wipo.int/
[3] Danish Patent Office. (2022). Patent Filing Guidelines. Retrieved from https://danishpatentandregistrationoffice.dk/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.